Report cover image

Tardive Dyskinesia Therapeutics Global Market Report 2025

Published Jul 07, 2025
Length 175 Pages
SKU # BRC20166227

Description

Tardive Dyskinesia Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tardive dyskinesia therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for tardive dyskinesia therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tardive dyskinesia therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug: Deutetrabenazine; Valbenazine; Other Drugs

2) By Product Type: Solid Dosage Forms; Tablets; Capsules; Liquid Dosage Form; Injection

3) By Application: Antipsychotic-Induced Tardive Dyskinesia; Other Drug-Induced Tardive Dyskinesia; Idiopathic Tardive Dyskinesia

4) By End-User: Hospitals; Clinics; Specialty Treatment Centers; Homecare Settings

Sub Segments:

1) By Deutetrabenazine: Dosage Forms; Line Of Therapy; Distribution Channel

2) By Valbenazine: Dosage Forms; Patient Age Group; Distribution Channel

3) By Other Drugs: Drug Class Or Type; Dosage Forms; Treatment Duration

Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Teva Pharmaceutical Industries Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Tardive Dyskinesia Therapeutics Market Characteristics
3. Tardive Dyskinesia Therapeutics Market Trends And Strategies
4. Tardive Dyskinesia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Tardive Dyskinesia Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Tardive Dyskinesia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tardive Dyskinesia Therapeutics Market Growth Rate Analysis
5.4. Global Tardive Dyskinesia Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tardive Dyskinesia Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tardive Dyskinesia Therapeutics Total Addressable Market (TAM)
6. Tardive Dyskinesia Therapeutics Market Segmentation
6.1. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Deutetrabenazine
Valbenazine
Other Drugs
6.2. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Dosage Forms
Tablets
Capsules
Liquid Dosage Form
Injection
6.3. Global Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotic-Induced Tardive Dyskinesia
Other Drug-Induced Tardive Dyskinesia
Idiopathic Tardive Dyskinesia
6.4. Global Tardive Dyskinesia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Specialty Treatment Centers
Homecare Settings
6.5. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Deutetrabenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dosage Forms
Line Of Therapy
Distribution Channel
6.6. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Valbenazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dosage Forms
Patient Age Group
Distribution Channel
6.7. Global Tardive Dyskinesia Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Class Or Type
Dosage Forms
Treatment Duration
7. Tardive Dyskinesia Therapeutics Market Regional And Country Analysis
7.1. Global Tardive Dyskinesia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tardive Dyskinesia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tardive Dyskinesia Therapeutics Market
8.1. Asia-Pacific Tardive Dyskinesia Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tardive Dyskinesia Therapeutics Market
9.1. China Tardive Dyskinesia Therapeutics Market Overview
9.2. China Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tardive Dyskinesia Therapeutics Market
10.1. India Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tardive Dyskinesia Therapeutics Market
11.1. Japan Tardive Dyskinesia Therapeutics Market Overview
11.2. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tardive Dyskinesia Therapeutics Market
12.1. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tardive Dyskinesia Therapeutics Market
13.1. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tardive Dyskinesia Therapeutics Market
14.1. South Korea Tardive Dyskinesia Therapeutics Market Overview
14.2. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tardive Dyskinesia Therapeutics Market
15.1. Western Europe Tardive Dyskinesia Therapeutics Market Overview
15.2. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tardive Dyskinesia Therapeutics Market
16.1. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tardive Dyskinesia Therapeutics Market
17.1. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tardive Dyskinesia Therapeutics Market
18.1. France Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tardive Dyskinesia Therapeutics Market
19.1. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tardive Dyskinesia Therapeutics Market
20.1. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tardive Dyskinesia Therapeutics Market
21.1. Eastern Europe Tardive Dyskinesia Therapeutics Market Overview
21.2. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tardive Dyskinesia Therapeutics Market
22.1. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tardive Dyskinesia Therapeutics Market
23.1. North America Tardive Dyskinesia Therapeutics Market Overview
23.2. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tardive Dyskinesia Therapeutics Market
24.1. USA Tardive Dyskinesia Therapeutics Market Overview
24.2. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tardive Dyskinesia Therapeutics Market
25.1. Canada Tardive Dyskinesia Therapeutics Market Overview
25.2. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tardive Dyskinesia Therapeutics Market
26.1. South America Tardive Dyskinesia Therapeutics Market Overview
26.2. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tardive Dyskinesia Therapeutics Market
27.1. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tardive Dyskinesia Therapeutics Market
28.1. Middle East Tardive Dyskinesia Therapeutics Market Overview
28.2. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tardive Dyskinesia Therapeutics Market
29.1. Africa Tardive Dyskinesia Therapeutics Market Overview
29.2. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tardive Dyskinesia Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tardive Dyskinesia Therapeutics Market Competitive Landscape And Company Profiles
30.1. Tardive Dyskinesia Therapeutics Market Competitive Landscape
30.2. Tardive Dyskinesia Therapeutics Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Tardive Dyskinesia Therapeutics Market Other Major And Innovative Companies
31.1. Otsuka Pharmaceutical Co. Ltd.
31.2. Sun Pharmaceutical Industries Ltd.
31.3. Dr. Reddy’s Laboratories Ltd.
31.4. Lundbeck A/S
31.5. Amneal Pharmaceuticals Inc.
31.6. Lupin Pharmaceuticals Inc.
31.7. Neurocrine Biosciences Inc.
31.8. Luye Pharma Ltd.
31.9. Lannett Co. Inc.
31.10. SteriMax Inc.
31.11. Zydus Cadila Healthcare Ltd.
31.12. Adamas Pharmaceuticals Inc.
31.13. Mitsubishi Tanabe Pharma Corporation
31.14. SOM Biotech Ltd.
31.15. Addex Therapeutics
32. Global Tardive Dyskinesia Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tardive Dyskinesia Therapeutics Market
34. Recent Developments In The Tardive Dyskinesia Therapeutics Market
35. Tardive Dyskinesia Therapeutics Market High Potential Countries, Segments and Strategies
35.1 Tardive Dyskinesia Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Tardive Dyskinesia Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Tardive Dyskinesia Therapeutics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.